Medtronic plc
MDT (NYSE)
Medtronic plc stands out as a recession-resistant healthcare device company, offering essential medical products that appeal to risk-averse investors. With a dividend yield of 3.52%, it provides a reliable income stream despite recent challenges, reflected in a one-year return of -8.37% and a five-year return of -35.29%. Analysts maintain a positive outlook, with a median 12-month price target of $91.00 and a solid B+ rating, underscoring its potential for future recovery.
Pros:
- Diverse product portfolio in healthcare
- Recession-resistant stock
Cons:
- Recent negative returns
- Market competition
In conclusion, Medtronic plc (MDT) may be a suitable investment for risk-averse investors seeking stability and income through its 3.52% dividend yield, despite its recent underperformance. While the stock has faced challenges reflected in its returns, the company's essential product offerings and analysts' positive outlook suggest potential for future recovery, making it worth consideration for those prioritizing defensive healthcare investments.